Lived experience advocates
Cardiovascular disease is the number one cause of death worldwide. Coronary artery disease leading to heart attack and ultimately heart failure is the biggest contributor. There is no known cure for heart failure, other than organ transplantation. This …
Our approach
Our targeted career development initiatives support REACT staff and students in becoming skilled, confident researchers who will shape the field of advanced cardiac therapies for decades to come. Through team science and collaboration, and by fostering an …
Greg Palmer
Greg leads patient and public involvement and engagement (PPIE) and digital communications efforts for the MRC/BHF CoRE in Advanced Cardiac Therapies (REACT). He is based at the University of Edinburgh but supports work across all our partner …
Dr Nicola Haines
As REACT COO Nicola works to ensure that we have the strategic and operational capacity to allow the science to run smoothly while maximising the opportunities to reach our goals and deliver impact on behalf of our funders, partners and publics. In REACT, …
Professor Daniel Stuckey
Daniel is Professor of Cardiovascular Imaging at University College London. For over 20 years his team have been developing in vivo imaging technology bespoke to cardiac regenerative therapies. Through successive BHF Fellowships, his team have established …
Dr Hanna Groothuizen
Hanna is REACT’s Research Culture Manager, working to help build a research culture that enables us to achieve our scientific goals. We know that healthy cultures foster innovation, retention and research integrity, whereas unhealthy ones do the opposite. …
Dr Christopher Toepfer
Chris is Associate Professor of Cardiovascular Science at the University of Oxford and Co-director of the Oxford Organoid Hub. His group is interested in understanding changes in cellular function that are driven by acquired and inherited …
Animal research
At the MRC/BHF CoRE in Advanced Cardiac Therapies, we are aiming to discover new therapeutic targets and translate them into clinical products which can be delivered as medicines. Some of our research therefore requires the use of animal models. This may …
Dr Jacqueline Barry
Jacqueline is Chief Clinical Officer at Cell and Gene Therapy Catapult. Jacqueline has over 20 years of experience in biologics and advanced therapies. Her career has focused on supporting the translation of research from the laboratory bench through to …
Dr Liam McQueen
Liam is a cardiovascular scientist with expertise in bioinformatics focused on investigating disease progression in cardiovascular conditions. Liam's focus as part of REACT is to utilise his experience to investigate the cellular and molecular factors …